Interactive Research and Development   Report issue

For profit Phase 3
Founded: Singapore Singapore (2004)

Organization Overview

First Clinical Trial
2019
NCT03896685
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Interactive Research and Development | Interactive Research and Development (IRD)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bacterial Infections (Phase 3)

Communicable Diseases (Phase 3)

Gram-Positive Bacterial Infections (Phase 3)

Infections (Phase 3)

Mycobacterium Infections (Phase 3)

Tuberculosis (Phase 3)

Tuberculosis, Multidrug-Resistant (Phase 3)

Tuberculosis, Pulmonary (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 4